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ABSTRACT

Design and Synthesis of Pyridine-based Lectin Mimics (Carbohydrate Receptors). (May 2017)
Maxwell Addo, B.Sc. Dip. Ed. University of Cape Coast;
Chair of Committee: Dr. Daniel Mott

Macrocyclic molecules consisting of aromatic groups with amino side chains are known
to bind selectively to carbohydrates, mainly monosaccharides and oligosaccharides. Some of
these macrocyclic molecules, for example, Pyridine-based and Naphthyridine-based macrocyclic
structures, behave like carbohydrate receptors and bind selectively to carbohydrates in
aqueous solutions through hydrogen bonding, hydrophobic and electrostatic interactions.
Bipyridine receptors mimic natural lectins. A bipyridine receptor was designed and synthesized
from Tris(2-aminoethyl)amine and 2,2-bipyridine-4,4-dicarboxyaldehyde. The receptor was
purified and characterized using extraction, HPLC (High Performance Liquid Chromatography),
NMR (Nuclear Magnetic Resonance) spectroscopy and ESI-MS (Electrospray Ionization Mass
Spectrometry). Masses and peaks obtained matched the expected structure which was
synthesized. The binding constants between the bipyridine receptor and six selected sugars in
water were determined by UV-Vis (Ultraviolet Visible) spectroscopy titration. Studies confirmed
that the bipyridine receptor was able to bind to three of the sugars. The observed dissociation
constant values ranged from 0.16mM to 0.37mM. These values compared favorably with the
reported binding constants between a 1,8-naphthyridine receptor and monosaccharide
complexes, as well reported lectin/monosaccharide complexes in nature. The divalent version
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of the bipyridine receptor, which was expected to have better binding properties towards sugar
substrates, was also prepared using solid phase synthesis. Two of the sugars that were able to
bind to the bipyridine receptor occurred in high concentration in certain cancer tumor tissues.
It is expected that the bipyridine receptor and the findings in this research can serve as source
of information for further research work into early detection and treatment of cancer or other
cellular communications in which glycoconjugates are important.
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INTRODUCTION
Cell surfaces are covered by carbohydrates. Current research works have shown that
these carbohydrates are essential in cell-cell communication. The communication occurs by
cell-cell contact or by other particles attaching themselves to the cell-surface carbohydrates.
These particles that attach themselves to the cell-surface carbohydrates are highly specific to
the type of carbohydrate to which they attach. Effective communication will also depend on the
effectiveness of the binding between the cell-surface carbohydrates and their specific receptors
(Brandley et al., 1986; Lepenies et al., 2010; Reenberg et al., 2007).
Carbohydrates are considered one of the most important biomolecules in living organisms.
They are the most abundant group of biomolecules and make up a higher percentage than any
of the other groups of biomolecules in nature (Boyer, 2006). Chemically, carbohydrates are an
important family of organic compounds with their own unique functional group and set of
physical and chemical properties (Brown et al., 2006). In human nutrition, carbohydrates
constitute one of the main classes of nutrients (Dryden, 2008). Basically, carbohydrates are
known as reactants for energy production in living cells; for example, glucose, a
monosaccharide, reacts with oxygen to generate energy (Boyer, 2006). These basic roles of
carbohydrates have been known to scientists for a long time. Current research works, however,
have unearthed other important roles played by carbohydrates in living systems. One of such
roles is the function of carbohydrates in the area of biological recognition processes; a role
previously known to be associated with proteins and nucleic acids. Carbohydrates are now
viewed as playing prominent roles in areas of control and dissemination of information in living
__________
This thesis follows the model of Current Organic Chemistry Journal.
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cells (Boyer, 2006; Catterall et al., 1997; Davis et al., 1999; Sharon et al., 1987).
There are some important cellular processes that are known to be controlled fully or
partly by signals from cell-cell contact. Complex cell-surface codes may control intercellular
interactions including binding of certain agents to cells via cell-surface carbohydrates and
carbohydrate receptor interactions. For example, many immunoglobulins (antibodies) and
peptide hormones contain glycoprotein sequences, a sequence composed of a peptide chain
linked to a carbohydrate. Circulating enzymes cleave these carbohydrates and the liver
determines their degradation by recognizing differences in length of the carbohydrate portion
of the glycoprotein (Boyer, 2006; Devlin, 2011). This and other biological processes, show that
cell-surface carbohydrates play a role in cell-cell recognition. Carbohydrates are also essential
for other processes like immune response, pathogenesis, cell differentiation, metastasis, cell
colonization in tumor formation, and even in fertilization process between the sperm and ovum
(Catterall et al., 1997; Sharon et al., 1987; Striegler, 2003).
Some of the questions that initiated research into cell-cell communication were: in which
group of cell-surface molecules is a particular cell-surface code embedded; and, which types of
receptors detect the cell-surface code? Although research effort in this area of science has
intensified in recent times, very little is known about some of these molecules; their
biochemical mechanisms and how the signals obtained affect changes in cell and tissue
behaviors in living systems. Data from previous research have advanced the hypothesis that
cell-surface carbohydrates can act as cell-cell recognition molecules. For example, surface
carbohydrates on one cell can bind to receptors like lectins, and this can initiate a specific
interaction resulting in changes in cell behavior (Brandley et al., 1986).
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What has become more challenging in this area of research are the characteristics of cellsurface carbohydrates and the nature of carbohydrate receptors involved in the biological
recognition processes; as well the type of interactions in which they engage. Biological
recognition between cell-surface carbohydrates and their receptors can be very complex.
Receptors and other agents are highly specific as to the type of carbohydrates to which they
link. The structural diversity of carbohydrates in terms of linkages, ring size and functional
groups also add extra complexity to the study of these interactions. Two identical
monosaccharide units have the option of forming a maximum of eleven different disaccharides.
Natural carbohydrate-receptor recognitions may therefore involve complex and elaborate
processes. The processes may involve lots of different varieties of carbohydrate molecules.
They may also involve a lot different receptors which are highly specific for the type of
carbohydrates they can bond to. Current research works are also looking into the effectiveness
of the binding affinities between surface cell carbohydrates and their specific carbohydrate
receptors and processes of enhancing the effectiveness of these bindings for medicinal and
other uses (Brandley et al., 1986; Lepenies et al., 2010; Reenberg et al., 2007).
Research works into the use of synthetic carbohydrates for biological recognition and
drug delivery processes in the human body are ongoing. Research works into the use of
synthetic carbohydrate receptors for diagnostic study and drug delivery processes are also
ongoing. The process of designing a carbohydrate receptor that binds to carbohydrates in an
aqueous medium is a relatively new area of research. Carbohydrate receptors that bind to
carbohydrates in organic media have already been made (Mazik et al., 2006). However, cellular
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fluids are aqueous solutions; it will be of interest to make receptors which bind to
carbohydrates in aqueous media.
The proposed carbohydrate receptor will have to overcome obstacles like the structural
complexity of carbohydrates and the weak binding interactions between the receptor and the
carbohydrate. A macrocyclic receptor molecule, if properly designed, can have characteristics
to overcome these obstacles. It can be made water-soluble, possesses the structures suitable
for stronger binding between the receptor molecule and the substrate, etc. (Lee et al., 2011;
Brandley et al., 1986). The structure of a macrocyclic bipyridine molecule shows that it
possesses the characteristic parts needed to bind to carbohydrates through hydrogen bonding
and other interactions. This research work is about designing and synthesizing a macrocyclic
bipyridine carbohydrate receptor which can recognize and bind to carbohydrate substrates in
aqueous media (Boyer, 2006; Catterall et al., 1997; Davis et al., 1999; Holme & Peck, 1998;
Sharon et al., 1987).
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REVIEW OF LITERATURE
2.1 Cell-surface Carbohydrates
The name carbohydrates simply mean “hydrates of carbon”. Carbohydrates constitute a
family of organic compounds primarily made up of carbon, hydrogen and oxygen. They are
represented by the general formula Cx(H2O)y, with the ratio of H to O being equal to 2:1. In
addition to these three elements, some carbohydrates and their derivatives also contain sulfur,
nitrogen or phosphorus. A carbohydrate usually has a reactive ketone or aldehyde functional
group and one or more hydroxyl groups, so, carbohydrates can be viewed as polyhydroxy
aldehydes and ketones (Boyer, 2006; Brown et al., 2006).
Carbohydrates are widely distributed in both plant and animal tissues; together with
other organic macromolecules like proteins, lipids, and nucleic acids, they serve various
functions in living things. Some monosaccharides like glucose and fructose are used in energy
generation in living organisms; others like ribose and deoxyribose sugars are one of the main
components of nucleic acids. Some polysaccharides, like glycogen and starch, serve as chemical
stores for energy production. Some carbohydrates and their derivatives also serve as structural
components in living things; for example, the rigid cell wall structures in bacterial and plant
cells, cartilage in animals, and the exoskeleton of arthropods all consist of carbohydrates and
carbohydrate derivatives. Carbohydrates are also important raw materials for many
biochemical reactions in living cells; they are also used as industrial raw materials for
fermentation reaction for production of alcohol (Boyer, 2006; Solomons & Fryhle, 2004).
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Until recently, the knowledge and importance of carbohydrates has been limited to
these uses and functions already mentioned above. Over the past fifty years, research works
into other uses of carbohydrates have been growing steadily. One of such areas is the use of
carbohydrates in the control and dissemination of information in living cells. Numerous
biological particles, including antibodies, enzymes, hormones, glycoproteins, glycolipids, etc.
are known to bind to cell-surface carbohydrates, where they engage in this control and
dissemination of information in living cells (Bucior & Burger, 2004).

Figure 1. A diagram showing some of the chemicals and structures that can bind to cell-surface
carbohydrates (Magnani, 2009).

The biological process of cell-cell recognition enables carbohydrates to play significant
roles in embryogenesis, spermatogenesis, implantation, host-pathogen interaction, immune
response, cell differentiation, tumor cell colonization and metastasis. (Boyer, 2006; Brandley et
al., 1986; Brandley et al., 1987; Bucior & Burger, 2004; Lee et al., 2011; Lepenies et al., 2010).
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The various roles that cell-surface carbohydrates play in animals cannot be underestimated.
Cell-surface carbohydrates are known to play a unique role in the spread of cancer from the
disease origin to other parts of the body. Carbohydrates are essential in aiding cancer cells to
break away from their disease origin and are carried away to other areas of the body to
enhance the spreading of the disease. This is due to the phenomenon that when cells are
diseased or become cancerous, the carbohydrate on the cell surfaces changes. These changes
in cell-surface carbohydrates enable cancer cells to escape immune-surveillance and other
means by which they can be destroyed (Ghazarian et al., 2010).
Sialic acid, a type of cell-surface carbohydrate, occurs on cell surfaces in humans and
thus has exposed locations; coupled with the negative charge on them, they engage in cell-cell
recognition by either masking recognition sites or controlling the recognition. This phenomenon
is important in nervous system embryogenesis, inflammatory and immune response processes
(Buschiazzo & Alzari, 2008; Kwak et al., 2012; Rutishauser 2008). Most pathogens use the
production of sialic acids to evade the immune system of their hosts; others which cannot
produce sialic acid use the enzymes they produce to control or moderate the immune system
of their host (Devlin 2011; Severi et al., 2007). A strain of Salmonella enterica, S. taphi, uses
sialic acid on the surface of cells to fix itself to the cell surface during infection (Sakarya et al.,
2010). Some types of viruses, specifically certain types of Adenovirus and avian infectious
bronchitis virus have been known to use sialic acid molecules as cellular receptors (Arnberg et
al. 2002; Winter et al., 2006). The human influenza virus uses glycoproteins it produces to
attach to sialic acid in human cells (Thompson et al., 2006). Anti-influenza drugs are therefore
designed to be just like sialic acid derivatives; an example is Zanamivir, a drug that inhibits the
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function of the viral neuraminidase enzyme and thus prevents the reproduction of the virus.
(Cyranoski, 2005). Aged glycoproteins lose some of the sialic acid component. This makes it
possible for liver cells to easily detect and degrade these aged glycoproteins by using
proteolytic enzymes (Marshall et al., 1974). More than half of the sialic acid in the human body
is found in gangliosides in the human central nervous system. Gangliosides bind to toxins and
provide specific recognition determinants on cell surfaces. Certain polymers of sialic acid
control neural cell adhesion during embryonic development. Expression of sialic acids on cell
surfaces has been linked to metastasis of several human tumors; this means the behavior of
these cell-surface sialic acids can be studied and applied in treatment of tumors (Tang et al.,
1997). Sialic acid analysis in cell membranes is used to study not only malignant cancer growth,
but also, diabetes mellitus. Overexpression of sialic acid may be an indication of certain
malignant cancer growth, whereas under-expression may be an indication of diabetes mellitus
(Kwak et al., 2012).
Bacteria as well as their toxins attach themselves to cell-surface carbohydrates.
Symptoms linked to most bacterial diseases are caused by these toxins being attached to cellsurface carbohydrates and hence altering the normal functions of the host cell (De Greve et al.,
2007; Nizet & Esko, 2009). Lectins also link to cells via cell-surface carbohydrates like sialic
acids. Lectins are known to react this way with cells which have undergone malignant
transformation. This phenomenon is employed in bone marrow transplants in children and for
leukemia treatment (Sharon & Lis, 2002). Cell-surface carbohydrates are, therefore, important
when studying most biological processes including infections by bacteria and viruses,
interactions between the cells of the human body and cells of lower eukaryotes, specific
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binding of sperm to egg during fertilization in human reproduction and recirculation of
lymphocytes to diseased regions in the body (Catterall & Turner, 1997; De Greve et al. 2007;
Sharon and Lis, 2002).
As stated above, an important feature of cell-surface carbohydrates that research has
shown is the idea that cell-surface carbohydrates change with the onset of certain diseases. It is
known, for example, that cell-surface carbohydrates change with the onset of cancer and
inflammation (Couldrey & Green, 2000). The change can be in a form of the loss of the normal
or original carbohydrate and subsequent replacement with another; the overexpression of the
normal carbohydrate (Rodgers et al., 2000); the persistence of incomplete or truncated
structure of the normal carbohydrate; the accumulation of precursors of the original
carbohydrate; or the expression of certain new carbohydrates that do not normally occur on
healthy cells (Gorelik et al., 2001; Kannagi et al., 2004; Xu et al., 2005). This information may be
linked to the behavior of certain diseased cells as the disease progresses. The information
obtained from studying this may be used for diagnostic purposes and selective treatment for
those diseased cells. This phenomenon has led to research which divert attention to the
synthesis of chemically defined cell-surface carbohydrate analogs, as well as mimics of certain
structures or chemicals that interact with these cell-surface carbohydrates, to reveal the
mechanics of a potential cellular language involved in intercellular interactions, which then can
be used for disease detection and treatment.
Carbohydrates are among the most complex and varied natural products; sometimes,
even considered more complex and varied than proteins or nucleic acids. Their complexity and
variability originates from the fact that a single monosaccharide unit can form variety of bonds
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at multiple positions in its skeletal structure. Isomerism ensures that even the α- and the βisomeric linkages produce carbohydrates with different properties. Branching in the carbon
chain may also produce different carbohydrates most of which are naturally stable compounds.
Carbohydrate structures can be modified by replacing the hydroxyl group with other functional
groups

producing

different

functionalized

carbohydrates.

Glycoproteins,

glycolipids,

proteoglycans, glycosaminoglycans, sialic acids, etc. are all examples of functionalized
carbohydrates (Boyer, 2006; Gorelik et al., 2001; Solomons & Fryhle, 2004). Hence, cell surface
carbohydrates can be complex and varied. The binding affinities in ordinary carbohydrates are
very weak. However, when carbohydrates are converted into glycoproteins, glycolipids and
proteoglycans, the binding affinities increase dramatically and that is the reason why cellsurface carbohydrates are mostly in the form of glycoproteins, glycolipids and proteoglycans
(Bucior & Burger, 2004; Yoneda & Couchman, 2003).
2.2 Lectins
Carbohydrates on cell surfaces bind to other structures in the body. One of such
structures is lectin. The word “lectin”, first used by William Boyd in 1954, comes from the latin
word, “legere” which means “to select” (Lam & Ng, 2011). Lectins are carbohydrate-binding
proteins that are highly specific for their carbohydrate moieties. The occurrence of lectins in
nature has been known since the turn of the nineteenth century; however, research interest in
lectins only intensified about twenty years ago. Formally known as hemagglutinins, it was from
the seeds of Ricinus communis that the first lectin was isolated by Stillmark in 1888 (Gabius et
al., 2011; Sharon et al., 1987; Singh et al. 2011).
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Lectins are produced from non-immunogenic sources. Lectins are known to bind to
specific carbohydrates on cell surfaces in a non-catalytic manner. In terms of binding, lectins
can be monovalent or multivalent. The nature of the binding of lectins to carbohydrates
depends on the stereochemistry of the carbohydrates. A lectin has a carbohydrate-binding site
that binds to the carbohydrate ligand. The binding occurs through a type of “lock and key”
system which is then stabilized by a complex network of hydrogen bonds and van der Waals
forces. The binding between lectins and carbohydrates by hydrogen bonds involve the hydroxyl
groups in the carbohydrates and the polar groups on the amino acid residue in lectins (Singh et
al., 2011).
Lectins play many important roles in biological systems. Lectins are known to mediate
symbiotic activity between leguminous plants and the nitrogen-fixing bacterium Rhizobium. It is
also known that plant lectins play a role in protecting seedlings against fungal attack; for
example, a lectin in potato is known to protect young potato plants against Botrytis cinerea, a
phytopathogenic fungus (Sharon et al., 1990). Germination of spores of Neurospora crassa,
Aspergillus amstelodami, and Botryodiplodia theobromae are known to be inhibited by certain
lectins (Brambl et al., 1985). Lectins in marine algae are known to control certain biological
activities. Alga lectins from Eucheuma serra and Galaxaura marginata have been observed to
inhibit the fish pathogen Vibrio vulnificus (Liao et al., 2003). Lectins in alga gametes enhance
recognition and adherence during sexual reproduction (Bolwell et al., 1979; Han et al., 2012).
The phenomenon of yeast binding to carbohydrates via lectins is an important application in
the brewery and food industry (Singh et al., 2011). Lectins are involved in assessment of
protein folding in the endoplasmic reticulum (Gerlach et al., 2012). It is known that certain
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parasitic amoebae, fungi, bacteria and viruses attach themselves to the host cell by binding to
lectins; lectins, in this way, aid in specific recognition between the pathogens and their host
cells. Lectins are suspected of being involved in the storing and moving of certain carbohydrates
because of their ability to adhere to specific carbohydrates. Other important biological
functions lectins engage in include removing glycoproteins from the circulatory system;
recognizing and delivering hydrolytic enzymes to lysosomes; exclusively detecting
carbohydrates found on the surface of cells of pathogens; and massing of leucocytes to sites of
inflammation. In medicine, a lectin, PHA-L, is used to trace the path of efferent axons, while,
Banlec, a lectin from banana is used to inhibit HIV-1 in-vitro. Lectins are also involved in food
allergies and sensitivities, inflammation and autoimmune diseases (Balzarini, 2006; Ji et al.,
2004; Singh et al., 2012).
The use of lectins in the study of carbohydrate recognition by proteins is gaining
momentum because of the ease of obtaining lectins and their large variety of sugar specificity.
Lectins are also being used to investigate the changes in cell-surface carbohydrates, from cell
differentiation, through metastasis, to, for example, giving a clue to the health status of a cell
(or tissue) and giving information on the onset of certain diseases. Future research would be
targeting the use lectins as carrier systems for cell-specific (or tissue-specific) drug delivery to
different diseased parts of the body (Sharon et al., 1989).
The classification of lectins is very broad due to the large number of lectins found in all
living organisms. There are animal, plant and microbial sources of lectins (Sharon & Lis, 2004).
Lectins have been isolated from peanuts (Arachis hypogaea), the European eel (Anguilla
anguilla) and the common mushroom (Agaricus bisporus). Bacterial lectins are commonly
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known as adhesins; certain bacteria fix themselves onto host cells using these adhesins via
glycans. The influenza virus fixes itself to erythrocytes by using hemagglutinin, a lectin that
recognizes sugars on the surfaces of erythtrocytes. According to the animal lectin homepage
(www.imperial.ac.uk/ research/animallectin/ctld/lectins.html), there are 13 groups of animal
lectins. Lectins can be classified based on the type of carbohydrates they recognize (Singh et al.,
2012). Lectins are termed as intracellular if they engaged in protein trafficking and sorting; they
can also be termed as extracellular if they engaged in signaling and pathogen recognition
(Kilpatrick, 2002; imperial research website).
The ability of lectins to bind to carbohydrates is an important factor to consider in
diseased cell recognition, drug delivery to specific sites in the human body, and the treatment
of diseased cells and tissues (Castonguay et al., 2011; Lakhtin et al., 2010; Singh et al., 2012). In
considering the use of lectins in the afore-mentioned areas, the binding properties and
specificity of lectins need to be assessed. In assessing these characteristics, there is the need to
consider a specific lectin and its characteristics. For the focus of this research, legume lectin is
being considered for this assessment because of its wide use in other biomedical researches
(Sharon & Lis, 2004).
2.3. Legume Lectins
There are several reasons why a discussion on legume lectins is important for this
research. Legume lectins form one of the largest families of lectins. Over 100 legume lectins
from different members of the family Leguminoseae have been isolated and characterized.
Most legume lectins were obtained from the seeds of various leguminous plants (Sharon & Lis,
1990; 2002). Legume lectins are the most extensively studied of all lectin families. Legume
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lectins can be easily obtained in their pure form and they easily show carbohydrate selectivity,
a phenomenon key to this research. Studies in legume lectins can readily be related to other
lectin families, and this is a key stepping stone into the studies of other lectins like the C-type
animal lectin which is important in medicinal and pharmaceutical research (Sharon & Lis, 1990;
2002).
A legume lectin consists of two to four single polypeptide chains known as protomers.
The protomers can be the same type or they can differ slightly. Each polypeptide chain usually
consists of about 250 amino acids. The amino acids engage in hydrogen bonding and
hydrophobic interactions with carbohydrates. Each polypeptide chain contains a site for
recognizing a carbohydrate; for each specific legume lectin, the carbohydrate recognizing sites
have the same carbohydrate specificity. These carbohydrate recognition sites are shallow
depressions on the surface of the protein and they serve as binding pockets (Sharon & Lis,
1990; 1998; 2002).
Studies have also shown that legume lectins possess hydrophobic binding sites in
addition to their carbohydrate binding sites. Most legume lectins bind strongly to
carbohydrates using Ca2+ ion, and a transition metal ion like Mn2+. These metal ions are so
essential that if the lectin is treated with acid to remove the metal ion, the lectin loses its
carbohydrate binding property (Sharon & Lis, 1990). This means that a legume lectin requires
positive electrostatic forces for it binding to carbohydrates. The positive charge on the lectin
binds to the negative charge on a cell-surface carbohydrate. Another important feature of
legume lectins is that they are generally glycoproteins; up to 10% of the lectin is a
carbohydrate. Currently, it is known that this carbohydrate portion plays no role in the sugar
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binding properties of legume lectin; when the carbohydrate is removed, the lectin still binds to
specific sugars (Sharon & Lis, 1990). Legume lectins, like any typical lectin, differ highly in their
carbohydrate specificity; this has been examined by analytical methods like equilibrium dialysis,
spectrophotometry, fluorimetry, and nuclear magnetic resonance. The binding constants
obtained from these studies show that legume lectins bind stronger to oligosaccharides than to
monosaccharides (Sharon & Lis, 1990).
Four main characteristics are thus expressed by legume lectin as a typical lectin: shallow
depressions serving as carbohydrate recognizing sites; electrostatic forces of attraction
envisaged by the presence of positively charged ions; a carbohydrate portion attached to a
polypeptide which plays no role in its sugar recognition; and finally, the polypeptide chain
known to generate the hydrogen bonds between the nitrogen (N) of the lectin and the oxygen
(O) of the hydroxide of the specific sugar the legume lectin is likely to bind to. These are the
important characteristics found in lectins that we seek to mimic. Three of these characteristics
are also very essential in lectin-carbohydrate complex formation.
2.4. Lectin mimics as artificial carbohydrate receptors
Two important ideas come to mind considering cell-surface carbohydrates and lectins:
cell surface carbohydrates changes due to health status of the cell (Baba & Catoi, 2007) and
lectins are specific in the type of carbohydrates they bind to (Berg et al., 2002; Sharon & Lis,
1998). These two phenomena can then be called into play in considering research work into
their applications in biomedical sciences. Lectins can be used to investigate the changes in cellsurface carbohydrates which can then give a clue to the health status of a cell, tissue or organ.
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Figure 2: A diagram showing various types interactions in lectin-carbohydrate binding. There is
an electrostatic force of attraction between the positively charged Ca 2+ ion and the O in the
carbohydrate or in any amino acid with an O; hydrogen bonds between the O of the OH in the
carbohydrate and the H of the NH of the amino acid (Protein - Carbohydrate binding, by
Goldon999 - Licensed under Creative Commons).
The information deduced from the investigation into the changes in cell-surface carbohydrates
can be used to predict the onset of certain diseases like cancer and malignant tumor (Tao et al.,
2008). Lectins can be employed as carrier systems for target drug delivery to different diseased
tissues in the body. This is another plausible research area which is still under investigation
(Gupta et al., 2009). Research works are also ongoing to produce synthetic carbohydrates to
cover specific cell surfaces as a clue in studying these cells if and when they are diseased; and
as carrier systems to deliver vaccines for cancer therapy (Zhu et al., 2009).
The research into the use of synthetic lectins to study diseased cells still faces some
challenges. The size of lectin as a protein molecule, the nature of proteins and their stability
under harsh body conditions show that using smaller molecules as lectin mimics may work
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more effectively in these areas of research already mentioned above (Jin et al., 2010). Lectins,
being proteins may be easily destroyed by enzymes in the body. Also, the making and storing of
lectins may be expensive because proteins are easily denatured by heat. It should also be noted
that introducing lectins into the body can cause immune shock (Janeway et al., 2001). Binding
affinities of lectins for natural carbohydrates in biological systems are very weak, although the
carbohydrate and the lectin being multivalent enhance binding (Dam et al., 2000).
2.5. Rationale behind the design of Bipyridine Carbohydrate receptor
The goal in this research is to design a receptor molecule that can recognize carbohydrates.
Such a carbohydrate receptor will be acting as a lectin mimic. There are two main hurdles that
need to be overcome. The first is the three dimensional complex nature of the monosaccharide
molecules. This makes it difficult for effective complex formation between a carbohydrate
receptor molecule and the carbohydrate. The second is the ability of the carbohydrate receptor
to have high specificity in differentiating between monosaccharides that are closely related
such as stereoisomers (Inouye et al., 1995).
Earlier research has shown that binding occurs between aromatic groups with amino acid
side chains when they come into contact with oligosaccharides moieties (Mazik et al., 2000).
This phenomenon makes macrocyclic structures important scaffolds in the design of
carbohydrate receptor molecules. Macrocyclic structures which contain aromatic groups such
as polypyridine units contain lipophilic cavities which serve as binding sites. Such structures can
be designed into carbohydrate receptors capable of using hydrogen bonding, electrostatic,
hydrophobic, pi-pi and CH-pi interactions to bind to carbohydrates. Finally, the macrocyclic
structures with the polypyridine units can exhibit strong absorption and fluorescence emission
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bands. Changes in their absorption due to carbohydrate-receptor complex formation can be
studied and stability constants of complexes formed can be determined and used in analyzing
effectiveness of complexes formed (Mazik et al., 2000, Mensah & Cudic, 2011).
Prior research shows that carbohydrate receptors designed from macrocyclic structures
containing 1,8-naphthyridine units bind effectively to carbohydrates in aqueous media (Mensah
& Cudic, 2011). The presence of 1,8-naphthyridine units in the receptor is also known to
increases the compounds affinity to carbohydrates in organic media (Mazik et al., 2000).
The 2,2-bipyridine moiety is the structure being considered in the design of carbohydrate
receptor in this research work.
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N
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Figure 3: Naphthyridine moiety

N

N

Figure 4: Bipyridine moiety

As shown in Figs. 3 and 4, the 2,2-bipyridine moiety resembles the 1,8-naphthyridine moiety
and therefore it is being hypothesized that a carbohydrate receptor can be designed from 2,2bipyridine moiety. Also, the structure of the bipyridine moiety shows that rotation of the rings
is possible because the two aromatic rings are joined by a single bond, unlike in the case of the
naphthyridine moiety in which the two aromatic rings are fused. The rotation in the bipyridine
moiety will allow the proposed receptor to twist around and bind to sugars more strongly than
the receptor produced from the naphthyridine moiety. The receptor produced from the
bipyridine moiety is expected to have high entropy because of the flexibility of its building
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blocks, but then, when it binds to sugars, it will lose entropy, which is expected to be gained in
its enthalpy (Mensah & Cudic, 2011).
The purpose of this research is to design, synthesize, purify, characterize and to
determine the binding constants of bipyridine-based macrocyclic carbohydrate receptors (see
Figs. 5 and 6). The free amino ends of Receptor 1 however can be explored to link through
coupling reactions to make a divalent receptor from Receptor 1 which will then have the ability
to engage in more extensive hydrogen bonding. Receptor 2 (see Fig. 6) has no free amino
groups at its ends. Dimerization of Receptor 2 to make it divalent to enhance its binding
efficiency may not be possible using the coupling process that can be used to dimerize Receptor
1. The dimer of Receptor 1 (see Fig. 7) will be more multivalent and this will enhance binding
and selectivity when it interacts with carbohydrates.
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The macrocyclic bipyridine receptor molecule produced from the dimerization of Receptor
1 (Fig. 3) should be able to recognize and bind to sugars in aqueous media. In the near future,
this work is expected to enhance the knowledge into how carbohydrates from cells of body
tissues affected by cancer and inflammation can bind to macrocyclic polypyridine molecules
which are acting as carbohydrate receptors. These receptors can then be used in other
biomedical research works.
The objectives of this project are to:
1. Create a reaction pathway for the synthesis the polypyridine macrocyclic receptor and
to use the reaction pathway created to synthesize the macrocyclic receptor.
2. To purify and characterize the receptor using HPLC, NMR and ESI-MS.
3. To study the binding properties of the receptor through spectrophotometric titration of
the receptor with sugar substrates.
4. To prepare the divalent version of Receptor 1 using solid phase organic synthesis.
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Figure 8: Synthetic scheme for production of Receptor 1 and Receptor 2

3.1.0. Receptor 1
The synthetic process adopted favors the formation of Receptor 1. Receptor 1 with its
side amino groups and its symmetrical nature can be used to prepare the multivalent version of

N
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the receptor which is expected to have enhanced binding properties. Receptor 2 on the other
hand cannot be used to prepare a multivalent receptor.
3.1.1. Synthesis of Receptor 1
The synthesis of the polypyridine receptors (Receptor 1) was prepared by dropping a solution of
Tris(2-aminoethyl)amine in acetonitrile/methanol mixture into a solution of 2,2-bipyridine-4,4dicarboxyaldehyde in acetonitrile/methanol mixture. To favor the formation of Receptor 1,
equal amounts of Tris(2-aminoethyl)amine and the 2,2-bipyridine-4,4-dicarboxyaldehyde were
used. The Tris(2-aminoethyl)amine solution was prepared by dissolving a 1.7 mmol of Tris(2aminoethyl)amine in CH3CN/CH3OH (20 mL, 1:1 V/V) mixture. The 2,2-bipyridine-4,4dicarboxyaldehyde solution was also prepared by dissolving a 1.7 mmol of 2,2-bipyridine-4,4dicarboxyaldehyde in CH3CN/CH3OH (150 mL, 1:1 V/V) mixture. The Tris(2-aminoethyl)amine
solution in a dropping funnel was then added drop by drop to the 2,2-bipyridine-4,4dicarboxyaldehyde solution in a round-bottom flask for a period of 30 minutes, with both
solutions at room temperature and under an atmosphere of nitrogen.
The resulting solution was stirred at room temperature for 18 hours using a magnetic
stirrer. After that, the solution was evaporated under reduced pressure without heating. The
solid formed was washed with diethyl ether. After that, the resulting solution was dried under
vacuum to yield a yellow powder. The yellow powder was dissolved in a CH2Cl2/CH3OH (150 mL,
2:1 V/V) mixture and cooled to 0oC. An 87.0 mg of NaBH4 was added slowly, and the solution
was stirred for 4 hours, while maintaining the temperature at 0 oC. The synthetic process was
complete after this. The solution was evaporated. The residue left was dissolved in water to
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stop the reaction. The solution formed was extracted three times, each with a 50 mL
CH2Cl2/CH3OH (9:1 V/V) mixture.
3.1.2. Characterization of the Receptor
Purification was carried out by dissolving the extract in methanol and using HPLC to
extract the receptor component. The structure of the receptor formed, the mass, as well as
which of the two receptors was formed was determined using HPLC, NMR and ESI-MS on both
the organic and aqueous extract of the residue.
3.1.3. Titration of the Receptor with sugars
A 50 mM phosphate buffer with a pH of 6.5 was prepared by weighing 7.05 g of sodium
sulfate and dissolving it in distilled water to form 1L of solution. The pH was determined and
adjusted to 6.5 by adding drops of HCl or NaOH to the solution. The phosphate buffer was used
as a solvent to prepare a solution of the receptor for the titration experiment. 2mL of the
receptor solution was used to dissolve a weighed amount of a named sugar to form the sugar
solution. This sugar solution was then used for titration.
2 mL of buffer solution was put into the first cuvette to serves as control in the UV-Vis
spectrophotometer. 2mL of the receptor solution was then put in the second cuvette. The first
reading was taken of the receptor solution. Then aliquots of the sugar solution (in 20µL and 50
µL increments) were added to the receptor solution in cuvette 2. The readings were taken for
the solution in cuvette 2 after each aliquot has been added. The readings were recorded, and
the data obtained was used in calculating the binding constants. The binding constants
(association constants) were calculated using the ReactLabTM equilibria.
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The binding constants were used to determine the binding efficiency between the
receptor and the sugar. This titration process was repeated for a selected number of sugars.
The data produced were compared to find out which sugar binds more effectively to the
receptor and those characteristics of the sugar which enable the effective binding was
analyzed. The sugars used for the titration were D-fructose, D-Galactose, D-maltose
monohydrate, D-glucose-6-phosphate sodium salt, α-D-glucose-1-phosphate disodium salt
hydrate and N-acetyl neuraminic acid.
3.2.0. Design of multivalent Receptor
The synthesis of polyvalent or multivalent version of Receptor 1 was made by first
synthesizing a polypeptide from individual amino acids using solid phase synthesis. The
polypeptide was then linked to Receptor 1 via diglycolic anhydride, also using solid phase
synthesis. The resulting substance was then dimerized using adipic acid.
3.2.1. Solid phase synthesis of a pentapeptide on NovaPeg organic resin
The diagram below shows the four main processes involved in the synthesis of the
pentapeptide (polypeptide). It involves functionalization of a NovaPeg organic resin by linking
the first amino acid to the organic resin. This is then followed by testing for the effectiveness of
the coupling reaction. Deprotection of the coupled amino acid follows, and then another amino
acid is linked to the first one. The processes of deprotection, coupling and testing the coupling
effectiveness are rotated until the five amino acids have been linked together.

26
resin
amino acid
X

P-AA-OH

+

loading

wash
AAP

AAP

deprotect
couple
P-AAOH
AAH

AAH

wash

Figure 9: The general scheme for the coupling reaction
3.2.2. Functionalization of the NovaPeg organic resin
The following chemicals were weighed using a balance: 0.3 mmol of NovaPeg organic
resin, 1.5 mmol of Fmoc AA1 (Fmoc-Ala-OH), 1.47 mmol of HBTU (N,N,N′,N′-Tetramethyl-O-(1Hbenzotriazol-1-yl)uronium

hexafluorophosphate),

3.0

mmol

of

DIPEA

((N,N-

Diisopropylethylamine).
The weighed NovaPegTM organic resin was swollen in DMF (N,N-Dimethylformamide) for
one hour. The DMF was then drained off. The HBTU and Fmoc AA1 were dissolved in 6 mL of
DMF. The weighed amount of DIPEA was then added to this solution. The resulting solution was
added to the swollen NovaPegTM organic resin.
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The resulting mixture was shaken for 3 hours using a Labquake™ shaker. After the
coupling reaction, the functionalized resin was washed thoroughly with DMF and then with
DCM (Dichloromethane). To remain swollen for subsequent stages of the work, the
functionalized resin was stored in 6 mL of DCM.
3.2.3. Testing the effectiveness of the coupling
The effectiveness of the coupling was tested using the UV-VIS spectrophotometer, as
well as, performing Kaiser Test on the functionalized resin sample.
First, a piperidine/DMF (2:8 V/V) mixture was prepared and used as the solvent for the
testing. 3mL of the solvent was put into the first UV cuvette to serve as control. 1mg of the dry
functionalized resin was weighed, and 3 mL of the piperidine/DMF (2:8V/V) mixture was added
to the sample for 4 minutes. The solvent was then put in the UV cuvette. The control and the
sample were both put into the UV-VIS Spectrophotometer and the absorbance recorded at
301nm. The percentage yield was then calculated using the equation:
mmol/g = (Abssolution - Absreference) / 1.28 x mg of sample
A yield of more than 90 % was observed.
Second, the Kaiser Test was done on the sample to confirm the results obtained from the
UV-VIS Spectrophotometer. The three solutions needed for the Kaiser Test were prepared. The
first solution (Kaiser Test Solution A) was prepared by dissolving16.5 mg of potassium cyanide
(KCN) in 25 mL of distilled water and 1 mL of this solution was added to 49 mL of pyridine. The
final solution was poured into a reagent bottle and labeled as Kaiser Test solution A. The second
solution was prepared by dissolving 1.0 mg of ninhydrin in 20 mL of ethanol. The final solution
was poured into a reagent bottle and labeled as Kaiser Test solution B. The third solution was
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prepared by dissolving 40 g of phenol in 20 mL of ethanol. This solution was poured into a
reagent bottle and labeled as Kaiser Test solution C.
The Kaiser Test was then done on some of the functionalized resin using the three Kaiser
Test solutions. A few of the functionalized resin beads were placed in an Eppendorf tube. The
beads were rinsed five times with ethanol to ensure that no unreacted coupling reagents were
present in the sample being tested. Two drops each of the three Kaiser Test solutions were
added to the resin and heated at 100oC for 5 minutes. The color of the mixture changed initially
from colorless to brown, indicating that the first coupling was complete.
3.2.4. Forming the dipeptide
The stored functionalized resin was taken and the DCM drained off. The functionalized
resin first went through deprotection. This was done by treating the functionalized resin with a
piperidine/DMF (2:8) mixture for 5 minutes. After that, the solution was drained off and the
resin washed two times with DCM. The resin was treated again with the piperidine/DMF
mixture for another 5 minutes, and finally, washed four times with DMF, and then, four times
again with DCM. A few of the functionalized resin beads was tested by a Kaiser Test. A blue
coloration confirmed that the amino (NH2) group in the alanine was free and available for the
next stage of the reaction.
The second Fmoc protected amino acid, Fmoc AA2 or Fmoc-Lys-D-OH was joined to the
first amino acid by a coupling reaction. A 1.5mmol of Fmoc AA2, 1.47 mmol of HBTU, 1.5 mmol
of HCTU (O-(6-Chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate)
and 3.0 mmol of DIPEA were weighed. The weighed amounts of Fmoc AA2, HCTU and HBTU
were dissolved in 6mL of DMF. The weighed amount of DIPEA was then added. The final
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mixture was added to the swollen functionalized resin. The mixture was shaken for two hours
at room temperature, using the Labquake™ shaker. After the coupling reaction, the
functionalized resin was washed four times with DMF and then, washed again four times with
DCM. The resin was stored in 6 mL of DCM for the subsequent stages of the reaction. A Kaiser
test performed on a sample of the resin gave brown coloration showing that the coupling was
complete.
3.2.5. Forming the pentapeptide
The three processes: deprotection to remove the Fmoc protection; coupling reaction to
link the next amino acid to the previous one; and a Kaiser Test to confirm the effectiveness of
the coupling reaction, was repeated three more times in succession to link three more Fmoc
protected amino acids (Fmoc –Asp(OALL)-OH, Fmoc-Met-OH and Fmoc-MePhe-OH) to the
dipeptide that was formed in 3.2.1.3 to form the pentapeptide chain.
3.2.6. Linking the diglycolic anhydride to the pentapeptide
The functionalized resin, which now consists of the NovaPeg™ organic resin linked to
the pentapeptide, was deprotected. A Kaiser test conducted on this polymer to ascertain the
availability of the free NH2 group yielded a blue coloration which showed that a free NH 2 group
was available. The following quantities of chemicals were weighed: A 1.5mmol of diglycolic
anhydride, 1.47 mmol of HBTU, 1.5 mmol of HCTU, and 3.0 mmol of DIPEA. These substances
were dissolved in DMF and added to the functionalized resin. The reaction mixture was shaken
for two hours using the Labquake™ shaker. A Kaiser Test on the product showed brown
coloration indicating that the coupling was complete.
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Figure 10: Linking diglycolic anhydride to Receptor 1 and the dimerization of Receptor 1 using
adipic acid.
3.2.7. Coupling the pentapeptide to the Receptor 1
Equimolar amounts of Receptor 1 and the polymer produced in 3.2.2.1 were mixed with
weighed amounts of HBTU, HCTU and DIPEA. The mixture was dissolved in DMF and taken
through a coupling reaction. The product, which was the pentapeptide, the diglycolic anhydride
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and Receptor 1 all linked and still linked to the resin, was kept for the next stage of the
synthesis.
3.2.8. Dimerization of Receptor 1
Weighed amounts of adipic acid, PyBop, and NMP were dissolved in DMA to form an activated
ester solution. The activated ester solution was added to the resin and shaken for four hours.
The resin was washed with DMF and then, washed with DCM. Another activated ester solution
of adipic acid, PyBop and NMP dissolved in DMA were added to the resin and shaken for 4
hours. The resin was washed with DMF and then with DCM.
3.2.9. Cleavage of the compound from the resin
A TFA/H2O mixture (95%/5% V:V) was prepared and added to the resin. The mixture was
shaken for 2 hours. The solvent was drained into an Erlenmeyer flask. The resin was washed
with more of the TFA/H2O mixture. Cold Et2O was added to precipitate the product leaving
behind the resin.

32

RESULTS
The main objective in this research was to synthesize Receptor 1, purify and characterize
the receptor produced; study the binding properties of the receptor with sugar substrates and
to prepare a divalent version of Receptor 1 using solid phase synthesis.
The receptor produced (Receptor 1) was mainly detected in the organic layer during the
characterization. Evidence for this was from the analytical results from HPLC, NMR and ESI-MS.
4.1. Result from HPLC

Figure 11: HPLC photograph of Receptor 1
The HPLC showed a single peak after the original crude product from the extraction
process had undergone several extraction processes using HPLC. Figure 10 shows a single peak
in that HPLC diagram, signifying a pure extract.
4.2. Result from NMR characterization of Receptor
1

H NMR (CD3OD, 400 MHz) δ: 7.79, 7.18 (2-pyridine), 2.75, 3.81 (CH2 or methylene).
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Figure 12: NMR H-1 for Receptor 1 (peaks and structure)

13

C NMR (CD3OD, 400 MHz) 149.8, 123.6 (2-pyridine), 49.1, 51.1 (aliphatic).

Figure 13: NMR C-13 (Peaks and structures)
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There were other peaks in the NMR data. These peaks comes from the solvent
(methanol) was used to dissolve the receptor for the analysis.
4.3 Result from Characterization with ESI-MS
+MS, 2.3-2.9min #(381-487)
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Figure 14: HR-ESI Spectrum of Receptor 1
In Fig. 14, the diagram for the mass spectrum shows a peak at mass 653.4551 [M+1].This
mass was in agreement to the calculated mass of Receptor 1 with molecular formula C 35H52N12.
4.4. Binding Studies
The carbohydrate substrates used for the titration against Receptor 1 were commercially
available. The six selected sugars were D-fructose, D-galactose, D-maltose monohydrate, D-
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glucose-6-phosphate sodium salt, α-D-glucose-1-phosphate disodium salt hydrate, and Nacetylneuraminic acid. The curve obtained in all cases where the sugar was able to bind to the
receptor shows that the absorbance decrease as the volume of the sugar solution added
increases (for the raw data). The raw data was further processed to obtain the dissociation
constants using the ReactLabTM equilibria.

Raw data Titration of Receptor 1 with
galactose
Absorbance
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Figure 15: A plot of absorption against volume of sugar solution for the titration of Receptor 1
using D-Galactose (0.0278 molar) @ 284.5 nm.
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Figure 16: A plot of absorption against wavelength for the titration of Receptor 1 using DGalactose (0.0278 molar)
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Figure 17: A plot of absorption against volume for the titration of Receptor 1 using D-Galactose
(0.0278 M) @ 284.5 nm.
Table 1: Binding (dissociation) constants for the titration between receptor 1 and the six
selected sugars
Sugars

Average Kd /M

D-fructose

1.5488 x 10-4

D-galactose

3.6539 x 10-4

D-maltose monohydrate

ND

D-glucose-6-phosphate sodium salt

ND

α-D-glucose-1-phosphate
hydrate
N-acetylneuraminic acid

disodium

salt ND
2.6903 x 10-4

Table 1 shows that three out of the six sugars titrated against the receptor were able to bind to
the receptor. The three sugars that were able to bind to Receptor 1 are D-Fructose, D-Galactose
and N-acetylneuraminic acid (also known as sialic acid).
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DISCUSSION
5.1. Synthesis of Receptor
The main reactants for the synthesis of the receptor are Tris(2-aminoethyl)amine and 2,2bipyridine-4,4-dicarboxyaldehyde. The reaction follows the general nucleophilic addition
reaction between an aldehyde and a primary amine followed by elimination of water. The
Tris(2-aminoethyl)amine is behaving as a typical primary amine whiles the 2,2-bipyridine-4,4dicarboxyaldehyde is behaving as an aldehyde.

RCOH + RHI +

RIINH2

RCH=NRII

+

H 2O

The reaction lead to the formation of an imine in the yellow powder obtained. The imine
formed was then reduced when the reducing agent sodium borohydride was added to form
another amine, this time, an amine with the aromatic groups in the 2,2-bipyridine-4,4dicarboxyaldehyde in it to give us the desired receptor.

RCH=NRII

Sodium borohydride

RCHNHRII

The synthetic process was not without challenges. There is the possibility of forming Receptor
1 or 2 depending on the mole ratio. Since Receptor I was preferred because of it amino group
side chains, its flexibility in conformation as well as it symmetrical nature, the reaction scheme
had to be manipulated to a 1:1 ratio. Nevertheless, some amount of Receptor 2 was formed
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and the mixture had to be purified. HPLC was used to purify and this involved several runs to
obtain enough sample for characterization and titration.
The coupling process in the production of the pentapeptide was difficult because amino
acids require multiple coupling before they could link to the resin or the functionalized resin.
This could have been eliminated by acquiring effective coupling apparatus which were
expensive and unavailable to me at the time of this research.
The sugars selected based on certain reasons. The six sugars were available and
economical to obtain. Also, these sugars have already been tested on the 1,8-Naphthyridine
receptors 3 and 4 with good results. So, their selectivity was to be confirmed with Receptor 1
and more importantly, their binding efficiency was to be studied with Receptor 1.
5.2. Selection of Sugar substrates
The dissociation constants (Kd) shows that Receptor 1 binds effectively to neutral
monosaccharides such as galactose and fructose as well as sialic acid which is negatively
charged. Affinities towards other sugar substrates tested, which include maltose monohydrate
(neutral), Glucose-6-phosphate sodium salt and glucose-1-phosphate disodium salt hydrate
(negatively charged) were non-determinable.
5.3. Binding
The binding constants of Receptor 1 and the selected sugars were compared with those
of two naphthyridine receptors. These two receptors have been named as Receptor 3 and
Receptor 4.
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Table 2: Comparison of the dissociation constants for 2,2-bipyridine and 1,8-naphthyridine
receptors. (NT means “not tested” and ND means “tested but not determined”).

Sugar substrate

Kd (M) value with Kd (M) value with Kd (M) value with
Receptor
1
(a Receptor 3 (a 1,8- Receptor 4 (a 1,8bipyridine
naphthyridine
naphthyridine
receptor)
Receptor
Receptor

D-galactose

3.7 x 10-4

1.6 x 10-3 (± 0.1)

≥ 1.0 x 10-2

D-glucose

NT

8.9 x 10-3 (± 0.9)

≥ 1.0 x 10-2

1,5-anhydroglucitol

NT

≥ 1.0 x 10-2

≥ 1.0 x 10-2

2-deoxy-D-glucose

NT

≥ 1.0 x 10-2

≥ 1.0 x 10-2

3-deoxy-D-glucose

NT

≥ 1.0 x 10-2

≥ 1.0 x 10-2

D-fructose

1.6 x 10-4

6.2 x 10-3 (± 0.5)

≥ 1.0 x 10-2

D-xylose

NT

≥ 1.0 x 10-2

≥ 1.0 x 10-2

D-ribose

NT

≥ 1.0 x 10-2

≥ 1.0 x 10-2

D-glucose-1-phosphate

ND

5.6 x 10-3 (± 0.1)

4.3 x 10-3 (± 0.1)

D-glucose-6-phosphate

ND

1.9 x 10-3 (± 0.1)

1.4 x 10-3 (± 0.05)

sialic acid

2.7 x 10-4

0.3 x 10-3 (± 0.01)

5.6 x 10-3 (± 0.3)

muramic acid

NT

≥ 1.0 x 10-2

2.5 x 10-3 (± 0.3)

D-trehalose

NT

3.2 x 10-3 (± 0.1)

≥ 1.0 x 10-2

D-gentiobiose

NT

6.3 x 10-3 (± 0.6)

≥ 1.0 x 10-2

D-maltose monohydrate

ND

NT

NT

Multipyridine macroreceptors are known to bind to sugars, especially monosaccharides
and oligosaccharides in aqueous solution (Mazik et al., 2000). These receptors behave like
natural lectins. They mimic lectins by binding to these sugars through charge-charge
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interactions, hydrogen bonding and hydrophobic interactions. The hydrogen bonding
interactions occurs between the hydroxyl groups in the monosaccharides and the amino groups
in the Receptor. The charge-charge interaction occurs between protonated amino groups and
lone pairs of electrons on the hydroxyl groups in sugars. In sialic acids, there are negative
charges due to the carboxylic functional group. The hydrophobic interaction occurs from the pipi stacking interactions created by the aromatic rings with the CH of the sugars (Mazik et al.,
2000, Mensah & Cudic, 2011).
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Figure 18: Receptor 3 (1,8-Naphthyridine dimer) and Receptor 4 (1,8-Naphthyridine trimer).
These are two other pyridine-based carbohydrate receptors from a different research. They
were found to bind to similar sugars that also bind to receptor 1 (Mensah & Curic, 2011).

Natural lectins are carbohydrate-binding structures. Lectins are highly selective in their
carbohydrate substrates (Berg et al., 2002; Sharon & Lis, 1998). Receptor 1, serving as a lectin
mimic, was able to bind to three out of the six monosaccharides. This shows that Receptor 1
exhibits selectivity. However, it also shows that Receptor 1 exhibits low selectivity because it
was able to bind to three different monosaccharides instead of one. Binding to only one
monosaccharide could have would have made Receptor 1 highly selective.
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Previous work on the binding effects of 1,8-naphthyridine receptors on similarly selected
monosaccharides showed that the conformational flexibility of the receptor is of importance in
discussing the degree of selectively of the receptor in question. The more flexible the receptor
in its conformational structure, the less selective the receptor is expected to be towards
monosaccharide substrates (Mensah & Cudic, 2011). For example, Figs. 16 and17 show two
different receptors made from 1,8 naphthyridine. Receptor 3 is more flexible than Receptor 4 in
terms of conformational structure. Table 2 shows that out of 14 monosaccharides titrated
against the two receptors, Receptor 3 was able to bind to 8, compared to receptor 4 which was
able to bind to 4 (Mensah & Cudic, 2011). Receptor 3, being more flexible in terms of
conformational structure, was able to bind to more sugars than Receptor 4.
The flexibility in the structure of the 1,2-bipyridine, due to the allowed rotation in it, makes
Receptor 1 even more flexible than either of the two 1,8-Naphthyridine receptors 3 and 4. This
implies that Receptor 1 was expected to be less selective based on this phenomenon alone.
However, Table 2 shows that certain sugars were able to bind to Receptor 3 but were not able
to bind to Receptor 1 despite the fact that structural conformation makes Receptor 1 more
flexible, and hence, less selective than Receptor 3. D-glucose-6-phosphate sodium salt and α-Dglucose-1-phosphate disodium salt hydrate were two monosaccharides that were able to bind
to Receptor 3 but were not able to bind to Receptor 1. This shows that apart from structural
conformation, other factors play a role in the Receptor’s (Receptor 1) selectivity.
Previous research has shown that the three sugars that were able to bind with Receptor
1, also binds to selected natural lectins which have N-terminal amino acid. Galactose binds to a
lectin isolated from the venom of Bothrops jararaca, a venomous snake. This lectin has an N-
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terminal amino acid and is a C-type lectin (Ozeki et al., 1994). Fructose also binds to a lectin
isolated from Musa acuminate (Del Monte banana) and this lectin also has an N-terminal amino
acid. (Cheung et al., 2009). N-acetyl neuraminic acid (Sialic acid) in nature binds to selectins,
which also have an N-terminal amino acid (Varki et al., 2009). Other research works also shows
that Galactose and Sialic acid binds to C-type lectins which include selectins (Varki et al., 2009).
Receptor 1 was able to bind to fructose and galactose but was not able to bind to
glucose. This phenomenon may be explained by the fact that, in aqueous solutions, both
galactose and fructose have a significant percentage of the furanose form (64% for galactose
and 22% for fructose, as compared to 0.3% for glucose) in equilibrium with the pyranose form
(Neuman, 2013). It is likely that Receptor 1 forms a stable structure with the furanose form as
compared with the pyranose form.
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Figure 19: structure of acetyl neuraminic acid

Acetyl-neuraminic acid was able to bind to Receptor 1. This may be due to the fact that
there was an extensive hydrogen bonding between Acetyl-neuraminic acid and the receptor
because of the NH, NH2 and OH groups. The structure of acetyl-neuraminic acid (Fig. 17) shows
OH groups and one NH2 group. The carbonyl groups in the structure of acetyl-neuraminic acid
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can possess charges due to resonance. Receptor 1 also shows NH and NH2 groups in its
structure. So, there can be charge-charge interaction between the negative charges generated
by the carbonyl groups in Acetyl-neuraminic acid and Receptor 1. Also, hydrophobic
interactions could have resulted from the aromatic groups in the receptor and the CH
structures in Acetyl-neuraminic acid. It is reasonable that Acetyl-neuraminic acid was able to
bind to receptor 1 with all these three forces, and especially, the intensive hydrogen bonding in
play.
The three sugars that were able to bind to Receptor 1 are also known to play vital roles in
the studying of certain ailments in humans. Fructose, as a carbohydrate, is known to fuel cancer
growth by providing an alternative carbon source for glycolysis (Ava et al., 2012). Fructose is,
therefore, known to induce pancreatic cancer proliferation (Liu et al., 2010). There seems to be
no evidence that fructose is a common cell-surface carbohydrate in cancer tissues. Fructose just
provides energy for cancer cell growth. The main idea in this research was to design and
synthesize a carbohydrate receptor that can bind to cell surface carbohydrates. This
phenomenon can then be used to study early detection of cancer growth in human. Receptor 1,
although it binds to fructose, cannot be used predict cancer growth based on its ability to bind
to fructose. However, galactose, one of the sugars that was able to bind to Receptor 1, is known
to play a role in cancer of the liver. Tumor cells in the liver express high galactose concentration
on their surface. The galactose expression is known to be directly proportional to the liver
metastasis (Yeatman et al., 1989). This means that Receptor 1 can be developed and used as a
target marker to study the occurrence and growth of cancer in the liver. N-acetylneuraminic
acid (or sialic acid), was another sugar that was able to bind to Receptor 1. It is known to occur

44

in high concentrations in malignant intracranial tumors and oral cancer (Xing et al., 1994).
Receptor 1 can be developed to be used in early diagnosis and to study the development of
these two types of cancer.
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CONCLUSION
The experimental results from the HPLC, NMR, and ESI-MS show that Receptor 1, a
macrocyclic 1,2 – bipyridine macromolecule, was synthesized from its reactants and under
specific conditions already stated above. The experimental results also show that Receptor 1
was able to bind to three sugars – fructose, galactose and sialic acid. Receptor 1, therefore, can
selectively recognize and bind to monosaccharides in aqueous solutions through intermolecular
forces and other noncovalent interactions. The dissociation constants of receptor-sugar
complexes ranged from 0.16 mM to 0.37 mM. Receptor 1 displayed selectivity which may be
based on factors like flexibility of the receptor (Mensah & Cudic, 2011). Other factors like
Receptor 1 having amine groups at both ends and the structure of the sugar in aqueous
solution (pyranose or furanose) might have also played a role in the selectivity. The dissociation
constant values show strong binding affinities between Receptor 1 and the three sugars. The
strongest binding was between Receptor 1 and fructose. The Kd values were also consistent
with binding constants between those sugars and some naturally occurring lectins. A galactose
binding lectin from Ricinus communis beans has a Kd value of 1.2 mM when it binds to galactose
(Podder et al., 1974). Del Monte™ Banana lectin, which is known to bind to fructose, does so at
a Kd value of 3.12 mM (Cheung et al., 2009). Hemolymph lectin from the cricket Teleogryllus
commodus, has a Kd value of 1 x 10-2 M when it binds to free sialic acid (Urich, 1990).
Based on the findings in this research, I conclude that Receptor 1 shows a new carbohydrate
receptor which can have promising applications in bio-chemical and bio-medicinal fields in the
future. Similar research on the design and synthesis of macrocyclic molecules are going on in
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different parts of the world with an aim to find an alternative to the detection and treatment of
cancer apart from the current chemotherapy.
Part of this research was to synthesize dimers of Receptor 1 via solid phase organic
synthesis (Fig. 7). Part of this was done. Time did not allow for the dimer produced to be
characterized and tested on its binding capabilities with sugars. In the future, a follow up to this
research will be to re-synthesize the dimer (Fig. 7) and test its binding capability with sugars.
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